 |
FDA Approval Activities for this Drug
Zomig (zolmitriptan) Nasal Spray, AstraZeneca NDA 21-450 9/30/03 10/10/03 10/10/03
| Zomig (zolmitriptan) tablets, AstraZeneca LP NDA 20-768/S-006 1/29/02 3/6/02
| Zomig (zolmitriptan) tablets & Zomig-ZMT (zolmitritpan) Orally Disintegrating Tablets, AstraZeneca LP NDA 20-768/S-010 & 21-231/S-03 10/9/02 10/21/02 | Zomig-ZMT (zolmitritpan) Orally Disintegrating Tablets, AstraZeneca NDA 21-231 2/13/01 3/30/01 3/30/01 | Zomig Indications: Acute treatment of Migraine. Zomig (zolmitriptan) nasal spray, AstraZeneca, Labeling Revision | Zomig (zolmitriptan) Tablets, AstraZeneca Pharma, Patient Population Altered | Zomig (zolmitriptan) Nasal Spray, AstraZeneca, Patient Population Altered | Zomig-ZMT (zolmitriptan) Orally Disintegrating Tablets, AstraZeneca Pharmaceuticals, Approval | Zomig (zolmitriptan) Tablets, AstraZeneca Pharmaceuticals, Labeling Revision | Zolmitriptan Tablets, Teva Pharmaceuticals, Tentative Approval | Zolmitriptan Tablets, Glenmark Generics Limited, Tentative Approval | Zomig, zolmitriptan, Tablet; Oral, Ipr, Labeling Revision
| Zomig-Zmt, zolmitriptan, Tablet, Orally Disintegrating; Oral, Astrazeneca, Labeling Revision | Zolmitriptan, zolmitriptan, Tablet, Orally Disintegrating; Oral, Zydus Pharms Usa Inc, Approval
| Zolmitriptan, zolmitriptan, Tablet; Oral, Glenmark Generics, Approval
| Zolmitriptan, zolmitriptan, Tablet; Oral, Apotex Inc, Approval
| Zolmitriptan, zolmitriptan, Tablet, Orally Disintegrating; Oral, Apotex Inc, Approval
| Zolmitriptan, zolmitriptan, Tablet, Orally Disintegrating; Oral, Glenmark Generics, Approval
| Zolmitriptan, zolmitriptan, Tablet; Oral, Mylan Pharms Inc, Approval
^ FDA's latest approval appears at the bottom of this list. ^
|